Cyagen is a Market Leader in Ophthalmology Research

Cyagen is a Market Leader in Ophthalmology Research

Cyagen is a leading provider of genetically modified rodent models and other molecular biology services and products to research laboratories worldwide. As a comprehensive contract research organization (CRO) solution provider, Cyagen  help with ophthalmology research.

We can help cure many diseases. These include:

  • Age-related macular degeneration (AMD)
  • Cataracts
  • Diabetic retinopathy
  • Glaucoma
  • retinal detachment
  • Uveitis

Why should you choose Cyagen for your eye research needs?

If you’re looking for a leading company specializing in ophthalmic research, look no further than Cyagen. Here are four reasons why you should entrust your research needs to us:

  1. We have a proven track record. Cyagen has been involved in ophthalmic research for over 15 years and has contributed to major advancements in the field.
  2. We have an experienced and high-quality professional team. Our team includes renowned scientists, engineers and doctors who are leaders in their fields.
  3. We provide state-of-the-art facilities and equipment. Our cutting-edge facilities allow us to conduct research at the highest level.
  4. We are committed to providing the best service to our customers. We understand the importance of our work and take pride in helping our clients achieve their goals.

With 16 years of gene editing model construction experience, Cyagen can provide you with a series of standardized ophthalmic gene therapy preclinical research solutions. Cyagen’s Gene Therapy CRO Platform has a number of senior technical experts who can provide you with a full range of guidance services in the fields of gene therapy strategy formulation, AAV vector design, custom animal models, and pharmacological efficacy evaluation.

About admin

Check Also

Blunders to Steer Clear of When Picking Your Office Back Wall Design

Having listed comprehensively the blunders to avoid when selecting the office back wall design, it …

Leave a Reply

Your email address will not be published. Required fields are marked *